Stocks
Iovance Biotherapeutics (IOVA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -206.9 | -260.8 | -342.7 | -398.9 | -427.4 | -447.8 | ||
| Changes by years, y/y, % | +61% | +26% | +31% | +16% | +7% | +27.2% | |||
Iovance Biotherapeutics. EBITDA US GAAP, bln rub
Iovance Biotherapeutics. EBITDA US GAAP, changes, %
Iovance Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Iovance Biotherapeutics (IOVA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -110.9 | -110.1 | -118.4 | -111.5 | -107.8 | -447.8 | |
| Changes by years, y/y, % | +28% | +17% | +18% | +4% | -3% | |||
| Changes by quarters, q/q, % | +4% | -1% | +8% | -6% | -3% | |||
